Literature DB >> 27475624

The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells.

Tomohisa Kato1, Hideaki Kouzaki2, Koji Matsumoto2, Junichi Hosoi3, Takeshi Shimizu2.   

Abstract

BACKGROUND: Calprotectin is a heterodimer complex of the S100A8 and S100A9 proteins, and has various functions as an innate mediator at the sites of inflammation. The aim of this study was to elucidate the roles of calprotectin in the eosinophilic chronic rhinosinusitis (ECRS).
METHODS: Allergen-induced production of calprotectin was evaluated in cultured normal human bronchial epithelial (NHBE) cells by ELISA and RT-PCR. We then examined the roles of calprotectin on Alternaria alternata (Alternaria)-induced production of thymic stromal lymphopoietin (TSLP) and IL-25 in NHBE cells. The extracellular concentration and allergen-induced secretion of calprotectin in cultured primary nasal epithelial (PNE) cells were examined and compared between patients with ECRS and non-eosinophilic chronic rhinosinusitis (NECRS).
RESULTS: Alternaria, house dust mites, protease from Staphylococcus aureus, papain, trypsin, polyinosinic:polycytidylic acid and lipopolysaccharide stimulated calprotectin production in the cultured NHBE cells. The combination of calprotectin and ATP stimulated the production of TSLP and IL-25 in NHBE cells, and calprotectin stimulated Alternaria-induced production of TSLP and IL-25, which was suppressed by blocking P2 purinergic receptors and by treatment with siRNA for S100A8, S100A9 or calprotectin receptors (Toll-like receptor 4 or receptor for advanced glycation end products). Allergen-induced calprotectin production was significantly stimulated in PNE cells from patients with ECRS.
CONCLUSIONS: These results indicate that calprotectin enhances the allergen-induced Th2-type inflammatory responses in airway epithelial cells via the secretion of TSLP and IL-25, and that calprotectin secreted by the epithelial cells may be involved in the pathogenesis of ECRS.
Copyright © 2016 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calprotectin; Eosinophilic chronic rhinosinusitis; IL-25; TSLP; Th2-type inflammation

Mesh:

Substances:

Year:  2016        PMID: 27475624     DOI: 10.1016/j.alit.2016.06.011

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  6 in total

1.  The Innate Immune Protein S100A9 Protects from T-Helper Cell Type 2-mediated Allergic Airway Inflammation.

Authors:  Lauren D Palmer; K Nichole Maloney; Kelli L Boyd; A Kasia Goleniewska; Shinji Toki; C Noel Maxwell; Walter J Chazin; R Stokes Peebles; Dawn C Newcomb; Eric P Skaar
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

Review 2.  The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota.

Authors:  Bernhard Krismer; Christopher Weidenmaier; Alexander Zipperer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2017-10-12       Impact factor: 60.633

3.  Role of P2X7R in eosinophilic and non‑eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Yan Wang; Shan Chen; Wenwen Wang; Jianjun Chen; Weijia Kong; Yanjun Wang
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

Review 4.  Alternaria as an Inducer of Allergic Sensitization.

Authors:  Guadalupe Hernandez-Ramirez; Domingo Barber; Jaime Tome-Amat; Maria Garrido-Arandia; Araceli Diaz-Perales
Journal:  J Fungi (Basel)       Date:  2021-10-07

Review 5.  Calprotectin: An Ignored Biomarker of Neutrophilia in Pediatric Respiratory Diseases.

Authors:  Grigorios Chatziparasidis; Ahmad Kantar
Journal:  Children (Basel)       Date:  2021-05-21

6.  Suppressive effects of S100A8 and S100A9 on neutrophil apoptosis by cytokine release of human bronchial epithelial cells in asthma.

Authors:  Da Hye Kim; Ayoung Gu; Ji-Sook Lee; Eun Ju Yang; Ayesha Kashif; Min Hwa Hong; Geunyeong Kim; Beom Seok Park; Soo Jin Lee; In Sik Kim
Journal:  Int J Med Sci       Date:  2020-02-04       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.